Strong Interest in 14th Australian Microcap Investment Conference

24 listed companies and more than 400 investors will participate when the 14th Annual Australian Microcap Investment Conference is staged in Melbourne in October.

For a specialist investor event to run for 14 years you know it must be ticking all the right boxes, and that will certainly be the case when the latest event is held on Tuesday 21st and Wednesday 22nd October 2025 at the Sofitel on Collins in Melbourne.

Featuring emerging ASX-listed companies with a market capitalisation under $300 million, the conference will provide institutional investors, analysts, stockbrokers, fund managers, family offices, and professional investors with the opportunity to hear directly from a variety of Australia’s leading microcap company leaders.

24 ASX-Listed Companies

This year’s information packed event will include presentations from 24 ASX-listed companies, keynote addresses by fund managers focused on investing in the microcap sector and a well-known business journalist.

Keynote presenters confirmed to date include Wilson Asset Management portfolio manager Tobias Yao, while the IPO Showcase will be led by Brent Owens, chief executive officer of Vitrafy Life Sciences (ASX: VFY).

Presenters at the conference include Shane Ryan from BCAL Diagnostics (ASX: BDX); John Lorente from Big River Industries (ASX: BRI); Phil Hodgson from Calix (ASX: CXL); Justin Hales of Camplify Holdings (ASX: CHL); Sam Budiselik from Cash Converters International (ASX: CCV); Michael Baragwanath from Clime Investment Management (ASX: CIW); Peter McGrath of Comms Group (ASX: CCG); Scott Kirkland from EMVision Medical Devices (ASX: EMV); Mathew Cherian of Global Health (ASX: GLH); Iain Dunstan from Gratifii (ASX: GTI); Tom Eadie of Hawk Resources (ASX: HWK); Glenn Corrie from Hazer Group (ASX: HZR); Dennison Hambling from Intelligent Monitoring Group (ASX: IMB); Ross Anderson of Murray Cod Australia (ASX: MCA); Dr Camile Farah of Optiscan Imaging (ASX: OIL); Brad Thomas from Prophecy International Holdings (ASX: PRO); Dr Peter Smith of Race Oncology (ASX: RAC); Brendan Malone of Raiz Invest (ASX: RZI); Sam Allert from Reckon (ASX: RKN); Christopher Clark of RocketDNA (ASX: RKT); Bryan Carr of Roolife Group (ASX: RLG); Cheryl Maley of Starpharma Holdings (ASX: SPL); Andrew Coleman from Teaminvest Private Group (ASX: TIP); and Jason Carroll of Tryptamine Therapeutics (ASX: TYP).

Attendees will also be able to participate in numerous networking opportunities, including seated lunches and drinks at the end of each day.

Small Caps subscribers will have a unique opportunity to participate in the event through a discounted delegate rate of $395, a saving of $300 off the normal registration of $695, by using the discount code SMALLCAPS2025 when registering.

For further information and to register for the event please go to: www.microcapconferences.com